ACN Newswire

Fri Nov 13

Zhaoke Ophthalmology Announced First Patient Completes Three Year Enrollment in Phase III CHAMP Study of NVK-002

Written by ACN Newswire

HONG KONG, Nov 12, 2020 - (ACN Newswire) - Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. ("Zhaoke Hong Kong") is pleased to announce today that the first patient has completed three year enrollment in the Phase III CHAMP (Childhood Atropine for Myopia Progression) study carried out by its partner, Nevakar Inc. ("Nevakar"). The CHAMP Study...

ACN Newswire

Zhaoke Ophthalmology Announced First Patient Completes Three Year Enrollment in Phase III CHAMP Study of NVK-002

Coronavirus while pregnant or giving birth: here's what you need to know

How much food should my child be eating? And how can I get them to eat more healthily?

Indonesia’s democratic masses brought victory to Jokowi

Understanding emotions is nearly as important as IQ for students' academic success

Labor and Greens compromised on Registered Organisations and ABCC legislation

Strategies to Protect Your Credit Score While Shopping for a Home Loan

There's no argument or support for allowing schools to discriminate against LGBTIQ teachers

View from The Hill: Kristina Keneally vs Peter Dutton should produce plenty of political bloodsport

'The Australian government is not listening': how our country is failing to protect its children

The A Bit na Ta exhibition reminds us of our forgotten links to Papua New Guinea

As Indigenous incarceration rates keep rising, justice reinvestment offers a solution